C3orf34 抗体 (AA 1-163) (Biotin)
Quick Overview for C3orf34 抗体 (AA 1-163) (Biotin) (ABIN7147396)
抗原
See all C3orf34 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-163
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Centrosomal protein of 19 kDa protein (1-163AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - C3orf34 (Chromosome 3 Open Reading Frame 34 (C3orf34))
- 
                                            别名
- CEP19
- 
                                            背景
- 
                        Background: centriole, centrosome, ciliary basal body, spindle pole Aliases: CEP19 antibody, C3orf34 antibody, HSD5 antibody, Centrosomal protein of 19 kDa antibody, Cep19 antibody 
- 
                                            UniProt
- Q96LK0
 抗原
- 
                    
 
                                     
                                     
                                    